The latest financial statement is for the quarter ending 2025-09-30.
| Cash Flow | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|
| Net income | 1,820,558 | 0 | 0 |
| Interest earned on cash held in trust | 2,068,698 | - | - |
| Prepaid expenses | 317,147 | - | - |
| Related party payable | 30,000 | - | - |
| Accrued expenses | 129,878 | -226,408 | - |
| Net cash used in operating activities | -405,409 | -226,408 | 0 |
| Cash deposited into trust | 200,000,000 | - | - |
| Net cash used in investing activities | -200,000,000 | - | - |
| Proceeds from issuance of class a ordinary shares | 200,000,000 | - | - |
| Proceeds from issuance of founder shares | 25,000 | - | - |
| Proceeds from issuance of private placement warrants | 2,648,000 | - | - |
| Proceeds from working capital loans related party | - | 300,000 | - |
| Payment of offering costs | 1,641,412 | - | - |
| Net cash provided by financing activities | 200,731,588 | 300,000 | - |
| Net change in cash | 326,179 | 73,592 | 0 |
| Cash and cash equivalents at beginning of period | 0 | - | - |
| Cash and cash equivalents at end of period | 399,771 | - | - |
Vendome Acquisition Corp I (VNME)
Vendome Acquisition Corp I (VNME)